Report cover image

Global Eyedrops for Cataract Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 113 Pages
SKU # APRC20548136

Description

Summary

According to APO Research, The global Eyedrops for Cataract market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Eyedrops for Cataract is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Eyedrops for Cataract is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Eyedrops for Cataract is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Eyedrops for Cataract include Novartis AG, Allergan, Inc., Walgreens, Viva Opti-Free, Visine, Systane, Staples, Similasan Corporation and Rite Aid, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Eyedrops for Cataract, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eyedrops for Cataract.
The Eyedrops for Cataract market size, estimations, and forecasts are provided in terms of sales volume (W Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Eyedrops for Cataract market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Eyedrops for Cataract Segment by Company

Novartis AG
Allergan, Inc.
Walgreens
Viva Opti-Free
Visine
Systane
Staples
Similasan Corporation
Rite Aid
Meda Pharmaceuticals Inc
Clear eyes
Cigna
Bausch & Lomb Inc
Bausch & Lomb
Alcon
Eyedrops for Cataract Segment by Type

Phacolin
Carlin -U
Catalin
Others
Eyedrops for Cataract Segment by Application

Adult
Children
Eyedrops for Cataract Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eyedrops for Cataract market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eyedrops for Cataract and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eyedrops for Cataract.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eyedrops for Cataract manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Eyedrops for Cataract in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

113 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Eyedrops for Cataract Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Eyedrops for Cataract Sales Estimates and Forecasts (2020-2031)
1.3 Eyedrops for Cataract Market by Type
1.3.1 Phacolin
1.3.2 Carlin -U
1.3.3 Catalin
1.3.4 Others
1.4 Global Eyedrops for Cataract Market Size by Type
1.4.1 Global Eyedrops for Cataract Market Size Overview by Type (2020-2031)
1.4.2 Global Eyedrops for Cataract Historic Market Size Review by Type (2020-2025)
1.4.3 Global Eyedrops for Cataract Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Eyedrops for Cataract Sales Breakdown by Type (2020-2025)
1.5.2 Europe Eyedrops for Cataract Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Eyedrops for Cataract Sales Breakdown by Type (2020-2025)
1.5.4 South America Eyedrops for Cataract Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Eyedrops for Cataract Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Eyedrops for Cataract Industry Trends
2.2 Eyedrops for Cataract Industry Drivers
2.3 Eyedrops for Cataract Industry Opportunities and Challenges
2.4 Eyedrops for Cataract Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Eyedrops for Cataract Revenue (2020-2025)
3.2 Global Top Players by Eyedrops for Cataract Sales (2020-2025)
3.3 Global Top Players by Eyedrops for Cataract Price (2020-2025)
3.4 Global Eyedrops for Cataract Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Eyedrops for Cataract Major Company Production Sites & Headquarters
3.6 Global Eyedrops for Cataract Company, Product Type & Application
3.7 Global Eyedrops for Cataract Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Eyedrops for Cataract Market CR5 and HHI
3.8.2 Global Top 5 and 10 Eyedrops for Cataract Players Market Share by Revenue in 2024
3.8.3 2023 Eyedrops for Cataract Tier 1, Tier 2, and Tier 3
4 Eyedrops for Cataract Regional Status and Outlook
4.1 Global Eyedrops for Cataract Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Eyedrops for Cataract Historic Market Size by Region
4.2.1 Global Eyedrops for Cataract Sales in Volume by Region (2020-2025)
4.2.2 Global Eyedrops for Cataract Sales in Value by Region (2020-2025)
4.2.3 Global Eyedrops for Cataract Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Eyedrops for Cataract Forecasted Market Size by Region
4.3.1 Global Eyedrops for Cataract Sales in Volume by Region (2026-2031)
4.3.2 Global Eyedrops for Cataract Sales in Value by Region (2026-2031)
4.3.3 Global Eyedrops for Cataract Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Eyedrops for Cataract by Application
5.1 Eyedrops for Cataract Market by Application
5.1.1 Adult
5.1.2 Children
5.2 Global Eyedrops for Cataract Market Size by Application
5.2.1 Global Eyedrops for Cataract Market Size Overview by Application (2020-2031)
5.2.2 Global Eyedrops for Cataract Historic Market Size Review by Application (2020-2025)
5.2.3 Global Eyedrops for Cataract Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Eyedrops for Cataract Sales Breakdown by Application (2020-2025)
5.3.2 Europe Eyedrops for Cataract Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Eyedrops for Cataract Sales Breakdown by Application (2020-2025)
5.3.4 South America Eyedrops for Cataract Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Eyedrops for Cataract Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Novartis AG
6.1.1 Novartis AG Comapny Information
6.1.2 Novartis AG Business Overview
6.1.3 Novartis AG Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis AG Eyedrops for Cataract Product Portfolio
6.1.5 Novartis AG Recent Developments
6.2 Allergan, Inc.
6.2.1 Allergan, Inc. Comapny Information
6.2.2 Allergan, Inc. Business Overview
6.2.3 Allergan, Inc. Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Allergan, Inc. Eyedrops for Cataract Product Portfolio
6.2.5 Allergan, Inc. Recent Developments
6.3 Walgreens
6.3.1 Walgreens Comapny Information
6.3.2 Walgreens Business Overview
6.3.3 Walgreens Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Walgreens Eyedrops for Cataract Product Portfolio
6.3.5 Walgreens Recent Developments
6.4 Viva Opti-Free
6.4.1 Viva Opti-Free Comapny Information
6.4.2 Viva Opti-Free Business Overview
6.4.3 Viva Opti-Free Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viva Opti-Free Eyedrops for Cataract Product Portfolio
6.4.5 Viva Opti-Free Recent Developments
6.5 Visine
6.5.1 Visine Comapny Information
6.5.2 Visine Business Overview
6.5.3 Visine Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Visine Eyedrops for Cataract Product Portfolio
6.5.5 Visine Recent Developments
6.6 Systane
6.6.1 Systane Comapny Information
6.6.2 Systane Business Overview
6.6.3 Systane Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Systane Eyedrops for Cataract Product Portfolio
6.6.5 Systane Recent Developments
6.7 Staples
6.7.1 Staples Comapny Information
6.7.2 Staples Business Overview
6.7.3 Staples Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Staples Eyedrops for Cataract Product Portfolio
6.7.5 Staples Recent Developments
6.8 Similasan Corporation
6.8.1 Similasan Corporation Comapny Information
6.8.2 Similasan Corporation Business Overview
6.8.3 Similasan Corporation Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Similasan Corporation Eyedrops for Cataract Product Portfolio
6.8.5 Similasan Corporation Recent Developments
6.9 Rite Aid
6.9.1 Rite Aid Comapny Information
6.9.2 Rite Aid Business Overview
6.9.3 Rite Aid Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Rite Aid Eyedrops for Cataract Product Portfolio
6.9.5 Rite Aid Recent Developments
6.10 Meda Pharmaceuticals Inc
6.10.1 Meda Pharmaceuticals Inc Comapny Information
6.10.2 Meda Pharmaceuticals Inc Business Overview
6.10.3 Meda Pharmaceuticals Inc Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Meda Pharmaceuticals Inc Eyedrops for Cataract Product Portfolio
6.10.5 Meda Pharmaceuticals Inc Recent Developments
6.11 Clear eyes
6.11.1 Clear eyes Comapny Information
6.11.2 Clear eyes Business Overview
6.11.3 Clear eyes Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Clear eyes Eyedrops for Cataract Product Portfolio
6.11.5 Clear eyes Recent Developments
6.12 Cigna
6.12.1 Cigna Comapny Information
6.12.2 Cigna Business Overview
6.12.3 Cigna Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Cigna Eyedrops for Cataract Product Portfolio
6.12.5 Cigna Recent Developments
6.13 Bausch & Lomb Inc
6.13.1 Bausch & Lomb Inc Comapny Information
6.13.2 Bausch & Lomb Inc Business Overview
6.13.3 Bausch & Lomb Inc Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Bausch & Lomb Inc Eyedrops for Cataract Product Portfolio
6.13.5 Bausch & Lomb Inc Recent Developments
6.14 Bausch & Lomb
6.14.1 Bausch & Lomb Comapny Information
6.14.2 Bausch & Lomb Business Overview
6.14.3 Bausch & Lomb Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bausch & Lomb Eyedrops for Cataract Product Portfolio
6.14.5 Bausch & Lomb Recent Developments
6.15 Alcon
6.15.1 Alcon Comapny Information
6.15.2 Alcon Business Overview
6.15.3 Alcon Eyedrops for Cataract Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Alcon Eyedrops for Cataract Product Portfolio
6.15.5 Alcon Recent Developments
7 North America by Country
7.1 North America Eyedrops for Cataract Sales by Country
7.1.1 North America Eyedrops for Cataract Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Eyedrops for Cataract Sales by Country (2020-2025)
7.1.3 North America Eyedrops for Cataract Sales Forecast by Country (2026-2031)
7.2 North America Eyedrops for Cataract Market Size by Country
7.2.1 North America Eyedrops for Cataract Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Eyedrops for Cataract Market Size by Country (2020-2025)
7.2.3 North America Eyedrops for Cataract Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Eyedrops for Cataract Sales by Country
8.1.1 Europe Eyedrops for Cataract Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Eyedrops for Cataract Sales by Country (2020-2025)
8.1.3 Europe Eyedrops for Cataract Sales Forecast by Country (2026-2031)
8.2 Europe Eyedrops for Cataract Market Size by Country
8.2.1 Europe Eyedrops for Cataract Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Eyedrops for Cataract Market Size by Country (2020-2025)
8.2.3 Europe Eyedrops for Cataract Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Eyedrops for Cataract Sales by Country
9.1.1 Asia-Pacific Eyedrops for Cataract Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Eyedrops for Cataract Sales by Country (2020-2025)
9.1.3 Asia-Pacific Eyedrops for Cataract Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Eyedrops for Cataract Market Size by Country
9.2.1 Asia-Pacific Eyedrops for Cataract Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Eyedrops for Cataract Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Eyedrops for Cataract Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Eyedrops for Cataract Sales by Country
10.1.1 South America Eyedrops for Cataract Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Eyedrops for Cataract Sales by Country (2020-2025)
10.1.3 South America Eyedrops for Cataract Sales Forecast by Country (2026-2031)
10.2 South America Eyedrops for Cataract Market Size by Country
10.2.1 South America Eyedrops for Cataract Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Eyedrops for Cataract Market Size by Country (2020-2025)
10.2.3 South America Eyedrops for Cataract Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Eyedrops for Cataract Sales by Country
11.1.1 Middle East and Africa Eyedrops for Cataract Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Eyedrops for Cataract Sales by Country (2020-2025)
11.1.3 Middle East and Africa Eyedrops for Cataract Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Eyedrops for Cataract Market Size by Country
11.2.1 Middle East and Africa Eyedrops for Cataract Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Eyedrops for Cataract Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Eyedrops for Cataract Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Eyedrops for Cataract Value Chain Analysis
12.1.1 Eyedrops for Cataract Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Eyedrops for Cataract Production Mode & Process
12.2 Eyedrops for Cataract Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Eyedrops for Cataract Distributors
12.2.3 Eyedrops for Cataract Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.